MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0004899
Equitron Medica Private Limited - machinery and equipment in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹45 Cr
▲ 20% YoY
Net profit · FY 2024
₹2.08 Cr
Net margin 4.6%
EBITDA · FY 2024
₹4.27 Cr
EBITDA margin 9.5%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹51.54 Lakh
Issued & subscribed
Open charges
₹8 Cr
Satisfied ₹1.25 Cr
Company age
8 yrs
Est. 2018
Directors on board
4
As per MCA filings
About Equitron Medica Private Limited
Data last updated:
Equitron Medica Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the industrial testing and measurement equipment segment of the machinery and industrial equipment sector. It was incorporated on 03 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC303609. Its GSTIN is 27AAECE8994N1ZO (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹51.54 Lakh. It is led by directors including Hemant Sumanlal Shah (Managing Director) and Sachin Suhas Shetye (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 105 & 116 Vasan Udyog Bhavan Sun Mill Compound Lower Parel (West), Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2024, the company reported a revenue of ₹45 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹2.08 Cr (net margin 4.6%) and EBITDA of ₹4.27 Cr (EBITDA margin 9.5%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 11% over five years.
The company is associated with 1 brand: Medica Instrument. As per MCA filings, the company has open charges of ₹8 Cr and satisfied charges of ₹1.25 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 1 case is pending. The company has 7 deals on record (4 rights issues, 3 secondary share transfers); the latest was in March 2023. Its 4 peer companies in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities) are compared by revenue, 2 larger and 2 smaller; the largest is Angiplast Private Limited with revenue of ₹45.27 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2023, listing 1,774 overdue payments to 133 micro and small suppliers.
Equitron Medica Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0004899). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medicainstrument.com.
Company details
CIN U74999MH2018PTC303609
Registration Number 303609
Incorporation Date 03 January 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0004899
Key People
Hemant Sumanlal Shah Managing Director Sachin Suhas Shetye Whole-Time Director Sagar Hemant Shah Whole-Time Director Recognitions & Rankings of Equitron Medica
Contact details
Equitron Medica Private Limited's registered office is in Mumbai, Maharashtra. Its website is medicainstrument.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address105 & 116 Vasan Udyog Bhavan Sun Mill Compound Lower Parel (West), Mumbai, Maharashtra, India – 400013
- IndustryMachinery and Equipment, Industrial Testing & Measurement Equipment
To see the full contact details of Equitron Medica Private Limited, buy the company report.
Comprehensive company report
Equitron Medica Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Equitron Medica operates one associated brand: Medica Instrument. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and supplying medical and laboratory equipment in India, focusing on sterilization, incubation, and safety instruments. | medicainstrument.com |
Business activity
The main business activities of Equitron Medica are manufacturing and professional, scientific and technical. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Equitron Medica Private Limited, buy the company report.
Financials of Equitron Medica Private Limited
FY 2025 filings availableEquitron Medica Private Limited reported revenue of ₹45 Cr (up 20% YoY) for FY 2024.
Revenue · FY 2024
₹45 Cr ▲ 20%
Net profit · FY 2024
₹2.08 Cr margin 4.6%
EBITDA · FY 2024
₹4.27 Cr margin 9.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 24%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 18%
5 years · compounded
▲ 5%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 20% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.27 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.08 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.5% | ||||
| Net Profit Margin | 4.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Equitron Medica Private Limited, buy the company report.
Board of directors of Equitron Medica Private Limited
Equitron Medica has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Suhas Shetye | Whole-Time Director | 02 Apr 2018 | 8 Years 7 Months | Current |
| Hemant Sumanlal Shah | Managing Director | 03 Jan 2018 | 8 Years 10 Months | Current |
| Sagar Hemant Shah | Whole-Time Director | 03 Jan 2018 | 8 Years 10 Months | Current |
| Pallavi Hemant Shah | Whole-Time Director | 03 Jan 2018 | 8 Years 10 Months | Current |
Peer comparison
Equitron Medica Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Angiplast Private Limited | ₹45.27 Cr (FY 2025) | 14.0% | Kheda, Gujarat, India | |||
| Aktiv Technologies Private Limited | ₹45.04 Cr (FY 2025) | 43.0% | Faridabad, Haryana, India | |||
| Equitron Medica Private Limitedthis company | ₹45 Cr (FY 2024) | ₹2.08 Cr | 4.6% | 20.0% | Mumbai, Maharashtra, India | |
| Nano Therapeutics Private Limited | ₹43.93 Cr (FY 2025) | -18.0% | Surat, Gujarat, India | |||
| Nice Neotech Medical Systems Private Limited | ₹43.92 Cr (FY 2025) | 45.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Equitron Medica Private Limited, buy the company report.
Auditor
Equitron Medica Private Limited is audited by Shah Gupta & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Shah Gupta & Co | FY 2023 | 109574W |
Shareholding
The shareholding of Equitron Medica Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Equitron Medica Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8 Cr
Satisfied charges
₹1.25 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2018 | 100228250 | Others | ₹8 Cr | Open | |
| 05 Jan 2019 | 100233326 | Tjsb Sahakari Bank Limited | ₹10.4 Lakh | Satisfied | |
| 03 Jan 2018 | 100196403 | Tjsb Sahakari Bank Limited | ₹1 Cr | Satisfied | |
| 03 Jan 2018 | 100196408 | Tjsb Sahakari Bank Limited | ₹15 Lakh | Satisfied |
To see the full charge records of Equitron Medica Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Equitron Medica Private Limited has 7 deals on record (4 rights issues, 3 secondary share transfers); the latest was in March 2023.
Total deals
7
Rights issues
4
Secondary share transfers
3
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Rights issue | ₹40,000 | Investors: an individual |
| Mar 2022 | Rights issue | ₹5 Lakh | Investors: an individual |
| Mar 2021 | Rights issue | ₹11.4 Lakh | Investors: an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2020 | Rights issue | ₹11.9 Lakh | Investors: an individual |
To see the full deal history of Equitron Medica Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Equitron Medica Private Limited has 4 court cases on record: 3 filed by Equitron Medica, 1 filed against it. 1 case is pending and 3 are disposed.
Total cases
4
Filed by the company
3
Filed against the company
1
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Complaint ULP) | Filed against the company by an individual | Pending |
| High Court, CHHATTISGARH | Writ petition | Filed by the company against State of Chhattisgarh and 2 others | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against Hyde Smart Solutions | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed by the company against individuals | Disposed |
To see the full case history of Equitron Medica Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Equitron Medica Private Limited has 14 MSME Form 1 returns on record between 2019 and 2023, listing 1,774 overdue payments to 133 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 133)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Regal Engineering Co | |||
| an individual supplier | |||
| Heat Source | |||
| Innovative Instruments & Controls LLP | |||
| an individual supplier |
To see the full MSME payment records of Equitron Medica Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Equitron Medica has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECE8994N1ZO | Maharashtra | Active | 17 Jan 2018 |
To see the full GST registrations and return filing status of Equitron Medica Private Limited, buy the company report.
Recent activity
Equitron Medica Private Limited has 7 board changes on record since 2018: 4 appointments and 3 cessations. The latest: Sachin Suhas Shetye was appointed as Whole-Time Director on 02 Apr 2018.
Charges
A charge with Others of Rs. 8.00 Cr registered on 31 Dec 2018 with Charge ID 100228250 was modified on 17 Dec 2025.
AGM
Equitron Medica Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Equitron Medica Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 05 Jan 2019 via Charge ID 100233326 with Tjsb Sahakari Bank Limited was fully satisfied on 28 Jun 2022.
Charges
A charge registered on 03 Jan 2018 via Charge ID 100196403 with Tjsb Sahakari Bank Limited was fully satisfied on 28 Jun 2022.
Charges
A charge registered on 03 Jan 2018 via Charge ID 100196408 with Tjsb Sahakari Bank Limited was fully satisfied on 28 Jun 2022.
Charges
A charge with Tjsb Sahakari Bank Limited amounted to Rs. 0.10 Cr with Charge ID 100233326 was registered on 05 Jan 2019.
Charges
A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100228250 was registered on 31 Dec 2018.
Appointed
Sachin Suhas Shetye was appointed as Whole-Time Director.
Ceased
Hemant Sumanlal Shah ceased to be Director.
Ceased
Pallavi Hemant Shah ceased to be Director.
Ceased
Sagar Hemant Shah ceased to be Director.
6 earlier events are in the company report.
Frequently asked questions
Equitron Medica is an active private limited company based in Mumbai, Maharashtra, India. The company works in industrial testing and measurement equipment, within the machinery and equipment industry. It was incorporated on 03 January 2018 (8+ years old) and is registered under CIN U74999MH2018PTC303609.
Equitron Medica has 4 current directors:
- Hemant Sumanlal Shah - Managing Director
- Sachin Suhas Shetye - Whole-Time Director
- Sagar Hemant Shah - Whole-Time Director
- Pallavi Hemant Shah - Whole-Time Director
The latest financial statements of Equitron Medica on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Equitron Medica is 27AAECE8994N1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of Equitron Medica is U74999MH2018PTC303609. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Equitron Medica has 4 court cases on record: 3 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.
Equitron Medica was incorporated on 03 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Equitron Medica has 7 deals on record (4 rights issues, 3 secondary share transfers); the latest was in March 2023.
The peers of Equitron Medica by revenue are Angiplast Private Limited, Aktiv Technologies Private Limited, Nano Therapeutics Private Limited, Nice Neotech Medical Systems Private Limited, all in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities).
Sachin Suhas Shetye was appointed as Whole-Time Director on 02 Apr 2018. Hemant Sumanlal Shah ceased to be Director on 23 Jan 2018. Pallavi Hemant Shah ceased to be Director on 23 Jan 2018. Equitron Medica has 7 board changes on record in total.
Yes, Equitron Medica is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0004899).
Equitron Medica has 14 MSME Form 1 returns on record between 2019 and 2023, listing 1,774 overdue payments to 133 micro and small suppliers. The latest return was filed on 27 Oct 2023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages